Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening: Clinical Use for Excluding Diabetic Foot Infection with MRSA
- PMID: 32393485
- PMCID: PMC7318007
- DOI: 10.1128/AAC.00635-20
Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening: Clinical Use for Excluding Diabetic Foot Infection with MRSA
Keywords: MRSA; Staphylococcus aureus; diabetic foot infection; epidemiology; nasal screening; negative predictive value; prevalence.
Comment in
-
Reply to Sfeir, "Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening: Clinical Use for Excluding Diabetic Foot Infection with MRSA".Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00803-20. doi: 10.1128/AAC.00803-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32393484 Free PMC article. No abstract available.
Comment on
-
Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening for Patients with a Diabetic Foot Infection.Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02213-19. doi: 10.1128/AAC.02213-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 31988097 Free PMC article.
References
-
- Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. 2019. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200:e45–e67. doi: 10.1164/rccm.201908-1581ST. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
